Profile data is unavailable for this security.
About the company
Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.
- Revenue in USD (TTM)124.00k
- Net income in USD-14.69m
- Incorporated2008
- Employees49.00
- LocationEvaxion Biotech A/SBredgade 34E, Copenhagen KCOPENHAGEN 1260DenmarkDNK
- Websitehttps://www.evaxion-biotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioxytran Inc | 0.00 | -4.30m | 14.80m | 2.00 | -- | -- | -- | -- | -0.0297 | -0.0297 | 0.00 | -0.0017 | 0.00 | -- | -- | -- | -2,431.80 | -1,420.53 | -- | -- | -- | -- | -- | -- | -- | -7.69 | -- | -- | -- | -- | -73.71 | -- | -- | -- |
| Nuo Therapeutics Inc | 782.01k | -3.02m | 15.00m | -- | -- | 43.78 | -- | 19.19 | -0.071 | -0.071 | 0.0183 | 0.0075 | 0.4516 | 0.7856 | 4.30 | -- | -174.64 | -116.16 | -294.62 | -354.84 | 78.74 | 70.02 | -386.76 | -854.53 | 1.01 | -1,418.93 | 0.00 | -- | 442.12 | -14.99 | 0.0095 | -- | -- | -- |
| Chemomab Therapeutics Ltd - ADR | 0.00 | -19.34m | 15.36m | 20.00 | -- | -- | -- | -- | -26.80 | -26.80 | 0.00 | -- | 0.00 | -- | -- | 0.00 | -72.94 | -- | -92.90 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 12.39 | -- | -- | -- |
| Talis Biomedical Corp | 989.00k | -57.21m | 15.38m | 99.00 | -- | 0.2713 | -- | 15.55 | -31.44 | -31.44 | 0.5434 | 31.11 | 0.0092 | -- | 14.87 | 9,989.90 | -53.08 | -68.18 | -58.71 | -74.22 | 97.27 | -- | -5,784.73 | -1,615.96 | -- | -- | 0.00 | -- | -55.65 | -2.24 | 45.13 | -- | -1.83 | -- |
| Kintara Therapeutics Inc | 0.00 | -9.51m | 15.73m | 2.00 | -- | -- | -- | -- | -4.08 | -4.08 | 0.00 | 0.1071 | 0.00 | -- | -- | 0.00 | -131.55 | -220.94 | -185.60 | -329.97 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 40.24 | -- | 78.93 | -- |
| Nymox Pharmaceutical Corp | 0.00 | -4.87m | 15.86m | 3.00 | -- | -- | -- | -- | -0.0536 | -0.0536 | 0.00 | -0.0204 | 0.00 | -- | -- | -- | -255.75 | -264.40 | -- | -464.48 | -- | -- | -- | -13,001.67 | -- | -42.44 | -- | -- | -- | -- | 47.55 | -- | -- | -- |
| Galecto Inc | 0.00 | -30.83m | 16.02m | 13.00 | -- | 0.569 | -- | -- | -1.15 | -1.15 | 0.00 | 1.04 | 0.00 | -- | -- | 0.00 | -63.50 | -48.46 | -78.33 | -52.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 37.77 | -- | -- | -- |
| Evaxion Biotech A/S - ADR | 124.00k | -14.69m | 16.42m | 49.00 | -- | -- | -- | 132.45 | -56.83 | -56.83 | 0.0902 | -- | -- | -- | -- | 2,530.61 | -- | -100.11 | -- | -131.65 | -- | -- | -11,846.77 | -131,560.30 | -- | -- | -- | -- | -- | -- | 4.51 | -- | 65.53 | -- |
| Kazia Therapeutics Ltd (ADR) | 15.25k | -13.83m | 16.62m | 12.00 | -- | 1.56 | -- | 1,090.07 | -0.839 | -0.839 | 0.0008 | 0.3572 | 0.0007 | -- | 73.97 | -- | -63.98 | -46.35 | -82.39 | -54.75 | -- | -- | -90,714.45 | -497.17 | -- | -- | 0.1297 | -- | 979.43 | -28.31 | 18.19 | -- | -- | -- |
| Neurosense Therapeutics Ltd | 0.00 | -11.88m | 16.67m | 16.00 | -- | -- | -- | -- | -0.7299 | -0.7299 | 0.00 | -0.4488 | 0.00 | -- | -- | 0.00 | -350.36 | -- | -5,244.59 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 18.10 | -- | -- | -- |
| Microbot Medical Inc | 0.00 | -10.26m | 17.48m | 22.00 | -- | 2.56 | -- | -- | -0.8926 | -0.8926 | 0.00 | 0.4283 | 0.00 | -- | -- | 0.00 | -151.13 | -53.28 | -183.85 | -62.65 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 18.44 | -- | -31.76 | -- |
| Synlogic Inc | 3.21m | -73.22m | 17.56m | 6.00 | -- | 1.31 | -- | 5.48 | -10.62 | -10.62 | 0.4576 | 1.15 | 0.0495 | -- | -- | 534,166.70 | -113.09 | -40.57 | -134.57 | -43.82 | -- | -- | -2,284.68 | -3,245.93 | -- | -- | 0.00008 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
| Conduit Pharmaceuticals Inc | 0.00 | -2.42m | 17.72m | 7.00 | -- | -- | -- | -- | -0.0339 | -0.0339 | 0.00 | -0.042 | 0.00 | -- | -- | 0.00 | -97.97 | -- | -- | -- | -- | -- | -- | -- | -- | -25.68 | -- | -- | -- | -- | 89.05 | -- | -- | -- |
| Sensei Biotherapeutics Inc | 0.00 | -31.92m | 17.99m | 27.00 | -- | 0.3077 | -- | -- | -1.20 | -1.20 | 0.00 | 2.33 | 0.00 | -- | -- | 0.00 | -36.55 | -47.03 | -39.39 | -54.33 | -- | -- | -- | -- | -- | -- | 0.0241 | -- | -- | -- | 29.82 | -- | 42.16 | -- |
Data as of Jul 16 2024. Currency figures normalised to Evaxion Biotech A/S's reporting currency: US Dollar USD
7.31%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 31 Mar 2024 | 367.00k | 7.04% |
| Citadel Securities LLCas of 31 Mar 2024 | 8.14k | 0.16% |
| Beacon Capital Management LLC (Tennessee)as of 31 Mar 2024 | 4.86k | 0.09% |
| JPMorgan Securities LLC (Investment Management)as of 31 Mar 2024 | 705.00 | 0.01% |
| RhumbLine Advisers LPas of 31 Mar 2024 | 290.00 | 0.01% |
| Tower Research Capital LLCas of 31 Mar 2024 | 30.00 | 0.00% |
| Group One Trading LPas of 31 Mar 2024 | 0.00 | 0.00% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 0.00 | 0.00% |
| UBS Securities LLCas of 31 Mar 2024 | 0.00 | 0.00% |
| LM Advisors LLCas of 31 Mar 2024 | 0.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
